InnoCan Pharma Corporation (CSE:INNO)
Canada · Delayed Price · Currency is CAD 6.65
-0.15 (-2.21%)
At close: Mar 20, 2026
InnoCan Pharma Market Cap
InnoCan Pharma has a market cap or net worth of CAD 29.92 million as of March 20, 2026. Its market cap has decreased by -37.50% in one year.
Market Cap
29.92M
Enterprise Value
25.78M
Revenue
37.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.65
Market Cap Chart
Since September 25, 2019, InnoCan Pharma's market cap has increased from 1.06M to 29.92M, an increase of 2,715.73%. That is a compound annual growth rate of 67.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 29.92M | -0.75% |
| Dec 30, 2025 | 30.14M | -49.98% |
| Dec 31, 2024 | 60.26M | -27.47% |
| Dec 29, 2023 | 83.08M | 54.74% |
| Dec 30, 2022 | 53.69M | -72.99% |
| Dec 31, 2021 | 198.79M | 218.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Loblaw Companies | 72.27B |
| Dollarama | 50.04B |
| George Weston | 36.16B |
| Metro | 19.86B |
| Swiss Water Decaffeinated Coffee | 45.17M |
| Eastwood Bio-Medical Canada | 37.89M |
| Burcon NutraScience | 24.62M |
| Global Education Communities | 24.03M |